140 related articles for article (PubMed ID: 38834932)
41. A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck.
Harrison LB; Raben A; Pfister DG; Zelefsky M; Strong E; Shah JP; Spiro RH; Shaha A; Kraus DH; Schantz SP; Carper E; Bodansky B; White C; Bosl G
Head Neck; 1998 Sep; 20(6):497-503. PubMed ID: 9702535
[TBL] [Abstract][Full Text] [Related]
42. Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.
Yao M; Galanopoulos N; Lavertu P; Fu P; Gibson M; Argiris A; Rezaee R; Zender C; Wasman J; Machtay M; Savvides P
Head Neck; 2015 Nov; 37(11):1665-71. PubMed ID: 24954745
[TBL] [Abstract][Full Text] [Related]
43. Head and neck extra nodal NHL (HNENL)--Treatment Outcome and Pattern of failure--A Single Institution Experience.
Giridhar P; Mallick S; Bhasker S; Pathy S; Mohanti BK; Biswas A; Sharma A
Asian Pac J Cancer Prev; 2015; 16(15):6267-72. PubMed ID: 26434827
[TBL] [Abstract][Full Text] [Related]
44. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
45. Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.
Pajares B; Trigo JM; Toledo MD; Álvarez M; González-Hermoso C; Rueda A; Medina JA; de Luque V; Jerez JM; Alba E
BMC Cancer; 2013 Jan; 13():26. PubMed ID: 23331666
[TBL] [Abstract][Full Text] [Related]
46. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
[TBL] [Abstract][Full Text] [Related]
47. Stage I and II aggressive B-cell lymphomas of the head and neck: radiotherapy alone as a treatment option and the usefulness of the new prognostic index B-ALPS.
Hayabuchi N; Shibamoto Y; Nakamura K; Onizuka Y; Ogo E; Suzuki G; Toda Y
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):44-50. PubMed ID: 12504035
[TBL] [Abstract][Full Text] [Related]
48. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
49. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
Arvold ND; Willett CG; Fernandez-del Castillo C; Ryan DP; Ferrone CR; Clark JW; Blaszkowsky LS; Deshpande V; Niemierko A; Allen JN; Kwak EL; Wadlow RC; Zhu AX; Warshaw AL; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e337-43. PubMed ID: 22414286
[TBL] [Abstract][Full Text] [Related]
51. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).
Ghadjar P; Pöttgen C; Joos D; Hayoz S; Baumann M; Bodis S; Budach W; Studer G; Stromberger C; Zimmermann F; Kaul D; Plasswilm L; Olze H; Bernier J; Wust P; Aebersold DM; Budach V
Strahlenther Onkol; 2016 Aug; 192(8):552-60. PubMed ID: 27323753
[TBL] [Abstract][Full Text] [Related]
52. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
[TBL] [Abstract][Full Text] [Related]
53. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
[TBL] [Abstract][Full Text] [Related]
54. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival.
Zhao D; Zhou F; Liu W; Huang Z; Xu X; Zheng B; Liu C; Bai C; Liu J; Sun Y; Wang W; Xiao S
BMC Cancer; 2024 Mar; 24(1):340. PubMed ID: 38486204
[TBL] [Abstract][Full Text] [Related]
55. Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome.
Huguenin P; Glanzmann C; Taussky D; Lütolf UM; Schmid S; Moe K
Strahlenther Onkol; 1998 Aug; 174(8):397-402. PubMed ID: 9739379
[TBL] [Abstract][Full Text] [Related]
56. Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.
Song S; Wu HG; Lee CG; Keum KC; Kim MS; Ahn YC; Oh D; Park HJ; Lee SW; Park G; Moon SH; Cho KH; Kim YS; Won Y; Oh YT; Kim WT; Jeong JU
BMC Cancer; 2017 Aug; 17(1):598. PubMed ID: 28854890
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
58. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
59. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
[TBL] [Abstract][Full Text] [Related]
60. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck.
Shen C; Xu T; Huang C; Hu C; He S
Oral Oncol; 2012 May; 48(5):445-9. PubMed ID: 22209446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
